We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+7.76%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$4.75B
AUM Growth
+$529M
Cap. Flow
-$138M
Cap. Flow %
-2.91%
Top 10 Hldgs %
47.97%
Holding
745
New
128
Increased
150
Reduced
259
Closed
162

Sector Composition

Rank Sector Weight
1 Healthcare 32.35%
2 Technology 15.53%
3 Financials 11.99%
4 Real Estate 8.48%
5 Materials 5.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPWR icon
326
SunPower Inc
SPWR
$48.6M
$1.43M 0.03%
135,081
-1,666
-1% -$17.4K
ADT icon
327
ADT
ADT
$5.59B
$1.38M 0.03%
229,607
-16,575
-7% -$104K
SWKS icon
328
Skyworks Solutions
SWKS
$10.1B
$1.38M 0.03%
12,506
-3,500
-22% -$369K
HLVX
329
DELISTED
HilleVax
HLVX
$1.38M 0.03%
80,478
-789
-1% -$12.2K
ZURA icon
330
Zura Bio
ZURA
$542M
$1.37M 0.03%
+167,167
New +$1.34M
IFRX icon
331
InflaRx
IFRX
$253M
$1.36M 0.03%
+305,000
New +$1.37M
ZM icon
332
Zoom
ZM
$29.7B
$1.36M 0.03%
20,000
+5,000
+33% +$334K
VZIO
333
DELISTED
VIZIO Holding Corp.
VZIO
$1.35M 0.03%
+200,000
New +$1.55M
ADPT icon
334
Adaptive Biotechnologies
ADPT
$3.75B
$1.34M 0.03%
199,840
+21,254
+12% +$158K
PSQH icon
335
PSQ Holdings
PSQH
$14.3M
$1.33M 0.03%
8,619
-22,889
-73% -$3.49M
RIGL icon
336
Rigel Pharmaceuticals
RIGL
$733M
$1.32M 0.03%
102,677
+26,926
+36% +$364K
IRTC icon
337
iRhythm Holdings
IRTC
$4.21B
$1.31M 0.03%
12,529
-3,186
-20% -$383K
WELL icon
338
Welltower
WELL
$170B
$1.3M 0.03%
16,087
-22,285
-58% -$1.72M
ACRV icon
339
Acrivon Therapeutics
ACRV
$72.3M
$1.3M 0.03%
+100,000
New +$1.21M
FUSN
340
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
$1.28M 0.03%
274,568
+32,542
+13% +$141K
SVRA icon
341
Savara
SVRA
$1.19B
$1.28M 0.03%
400,352
-156,161
-28% -$367K
AUTL
342
Autolus Therapeutics
AUTL
$532M
$1.26M 0.03%
530,919
-226,089
-30% -$536K
JAQC
343
DELISTED
Jupiter Acquisition Corporation Common stock
JAQC
$1.23M 0.03%
120,173
-352,449
-75% -$3.58M
CCJ icon
344
Cameco
CCJ
$40.8B
$1.23M 0.03%
+39,300
New +$1.11M
OFIX icon
345
Orthofix Medical
OFIX
$432M
$1.23M 0.03%
68,032
+3,352
+5% +$62.6K
TRIS
346
DELISTED
Tristar Acquisition I Corp.
TRIS
$1.22M 0.03%
116,910
-2,635
-2% -$27.5K
RLAY icon
347
Relay Therapeutics
RLAY
$4.3B
$1.21M 0.03%
96,385
+52,285
+119% +$650K
BCAB icon
348
BioAtla
BCAB
$5.53M
$1.21M 0.03%
8,054
+3,153
+64% +$542K
MSTR icon
349
Strategy Inc
MSTR
$37.2B
$1.2M 0.03%
+35,050
New +$1.06M
GWRE icon
350
Guidewire Software
GWRE
$13.3B
$1.14M 0.02%
15,000
-87,500
-85% -$6.7M

Similar funds

UBS O'Connor's Q2 2023 Portfolio in Review

As of Q2 2023, UBS O'Connor held 745 positions worth $4.75B, up 13% from $4.22B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

UBS O'Connor's Q2 2023 filing shows 128 new, 150 increased, 259 reduced and 162 closed positions. Its largest new stake was PDC Energy, Inc.: 3,101,445 shares worth $221M. The largest sale was First Horizon, an estimated $179M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 21% a quarter earlier, followed by Technology and Financials.

  • UBS O'Connor's largest Q2 2023 buy was PDC Energy, Inc.: 3,101,445 shares worth $221M.
  • UBS O'Connor added most to Seagen Inc. Common Stock in Q2 2023, an estimated $253M increase.
  • UBS O'Connor's biggest Q2 2023 reduction was Tower Semiconductor, cutting an estimated $50.8M.
  • UBS O'Connor fully exited First Horizon in Q2 2023, selling an estimated $179M.
  • UBS O'Connor's ten largest holdings make up 48% of its $4.75B portfolio in Q2 2023.
  • UBS O'Connor opened 128 new positions and closed 162 in Q2 2023.
  • UBS O'Connor's portfolio value rose 13% quarter-over-quarter to $4.75B.

Based on UBS O'Connor's 13F filing for Q2 2023, filed 14 Aug 2023.